12
Views
7
CrossRef citations to date
0
Altmetric
Original Article

A Phase I Trial of Chlorambucil Administered in Short Pulses in Patients with Advanced Malignancies

, , , , , , & show all
Pages 371-375 | Published online: 11 Jun 2009

References

  • Everett J L, Roberts J R, Ross W CJ. Ary 1–2-halogen alkylamines. Part XIII. Some carboxylic derivatives of NN-di-2 chloroethyla-mine. J Chem Soc London 1983; 3: 2386
  • Sawitsky A, Rai K R, Glidwell O, et al. Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia. Blood 1977; 50: 1049–1059
  • Knopse W H, Loeb V, Jr, Huguley C M, Jr. Bi-weekly chlorambucil treatment of chronic lymphocytic leukemia. Cancer 1974; 33: 555–562
  • Newell O R, Clavert A H, Harrap K R. Studies on the pharmacokinetics of chlorambucil and prednimustine in man. Br J Clin Pharmacol 1983; 15: 253–258
  • Alberts D S, Chang S Y, Chen H-SG, et al. Comparative pharmacokinetics of chlorambucil and melphalan in man. Rec Results Cancer Res 1980; 74: 124–131
  • Alberts D S, Chang S Y, Chen H-SG. Pharmacokinetics and metabolism of chlorambucil in man: a preliminary report. Cancer Treat Rev 1979; 6(Suppl)9
  • Blank D W, Nanji A A, Schreiber D H, et al. Acute renal failure and seizures associated with chlorambucil overdose. J Toxicol Clin Toxicol 1983; 20: 361–365
  • Enck R E, Burnett J M. Inadvertent chlorambucil overdose in the adult. NY State J Med 1977; 77: 1480–1481
  • Galton D A, Israels L G, Nabarro J D, et al. Clinical trials of p-(di-2-chloroehylamino)- phenylbutiric acid (CB-1348) in malignant lymphoma. Br Med J 1955; 2: 1172
  • Burchenal J H. The newer nitrogen mustards in the treatment of leukemias. Radiology 1948; 50: 494–499
  • Goldin A, Noe H A, Landing B H, et al. A neurological syndrome induced by administration of some chlorinated tertiary amines. J Pharmacol Exp Ther 1948; 94: 249–261
  • Sternberg S S, Philips F S, Schaller J. Pharmacological and pathological effects of alkylatime agents. Ann NY Acad Sci, 68: 811–825
  • Conrad M E, Crosby W H. Massive nitrogen mustard therapy in Hodgkin's disease with protection of bone marrow by tourniquets. Blood 1960; 16: 1089–1103
  • Bethlenfalvay N C, Bergin J J. Severe cerebral toxicity after intravenous nitrogen mustard therapy. Cancer 1972; 29: 366–369

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.